Enoxaparin Sodium Injection
Product Images NDC 68001-463

Product Visual Gallery

This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 68001-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxaparin Sodium Injection 30mg/0.3ml Carton (Carton 5601a)

Packaging label for Enoxaparin Sodium Injection 30 mg/0.3 mL, provided in 10 single-dose syringes. The injectable solution is for subcutaneous use and supplied by BluePoint Laboratories. The label includes product identification, NDC number 68001-457-42, usage directions, storage instructions, and safety warnings.*

FDA Label Image

Enoxaparin Sodium Injection 40mg/0.4ml Carton (Carton 5602a)

The packaging label for Enoxaparin Sodium Injection, 40 mg/0.4 mL, single-dose syringes. The label includes directions for use with illustrated steps for subcutaneous injection. It states storage conditions and cautions, and notes that the product is Rx only. The labeler is BluePoint Laboratories, with manufacturer Amphastar Pharmaceuticals, Inc. The package contains 10 single-dose syringes with automatic safety devices.*

FDA Label Image

Enoxaparin Sodium Injection 60mg/0.6ml Carton (Carton 5603a)

Carton label for Enoxaparin Sodium Injection 60 mg/0.6 mL single dose syringes by BluePoint Laboratories. The packaging contains 10 syringes for subcutaneous injection. Label includes directions for use with illustrations, storage instructions, warnings, barcode, and manufacturer information.*

FDA Label Image

Enoxaparin Sodium 80mg/0.8ml Carton (Carton 5604a)

Packaging label for Enoxaparin Sodium Injection 80 mg/0.8 mL, containing 10 single-dose syringes. The label indicates the product is for subcutaneous injection and includes directions for use illustrations. Manufactured by Amphastar Pharmaceuticals and labeled for BluePoint Laboratories, this Rx-only product includes storage instructions and safety warnings.*

FDA Label Image

Enoxaparin Sodium Injection 100mg/ml Carton (Carton 5605a)

The packaging label for Enoxaparin Sodium Injection, 100 mg/mL, presents a box designed to hold 10 single-dose syringes. The label is marked for subcutaneous injection and includes dosing instructions with step-by-step illustrations. It highlights the product as Rx only, manufactured by BluePoint Laboratories with detailed storage conditions and warnings to keep out of reach of children.*

FDA Label Image

Enoxaparin Sodium Injection 120mg/0.8ml Carton (Carton 5606a)

Carton label for Enoxaparin Sodium Injection 120 mg/0.8 mL, subcutaneous injection in single-dose syringes. The package contains 10 syringes of 0.8 mL each, with 120 mg enoxaparin sodium derived from porcine intestinal mucosa. Labeler is BluePoint Laboratories. Includes directions for use illustrations and storage conditions (2-25°C with excursions permitted to 15-30°C). Warnings and manufacturer information are also present.*

FDA Label Image

Enoxaparin Sodium Injection 150mg/ml Carton (Carton 5607a)

Packaging label for Enoxaparin Sodium Injection 150 mg/mL, a subcutaneous injection. This label is for a carton containing 10 single-dose syringes of 150 mg strength by BluePoint Laboratories. The label includes directions for use with illustrated steps, storage instructions, and warnings.*

FDA Label Image

Enoxaparing Sodium Injection Usp Vial Carton (Carton 5608)

Packaging label for Enoxaparin Sodium Injection, USP by BluePoint Laboratories. The label shows a 300 mg/3 mL (100 mg/mL) multiple dose vial for subcutaneous or intravenous injection. Key details include storage instructions, dosage form, administration route, and manufacturer information.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 00

An instructional diagram showing a hand disposing of an Enoxaparin Sodium injection syringe by placing it needle-first into a labeled Sharps Disposal Container. The syringe's needle cover is visible, highlighting safe disposal practices for injection equipment.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 01

An instructional illustration showing a hand holding a pre-filled syringe labeled with a protective sleeve. An arrow indicates the direction of movement, likely demonstrating part of the preparation or administration process for an injection.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 02

An instructional illustration showing a hand holding a prefilled syringe for subcutaneous injection aimed at the lower abdominal area, indicating the proper injection site for Enoxaparin Sodium injection.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 03

An instructional illustration showing the administration of Enoxaparin Sodium injection by subcutaneous injection into the abdominal area. The image depicts a hand holding the syringe at a right angle to the skin, indicating correct injection technique.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 04

Instructional illustration showing a hand administering a subcutaneous injection using a syringe. The syringe is positioned at a 90-degree angle to the skin, with an arrow indicating the injection direction. The image demonstrates proper injection technique, likely for Enoxaparin Sodium injection.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 05

Illustration showing a hand pinching the skin on an abdomen, demonstrating a technique for subcutaneous injection administration.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 06

An instructional line drawing showing a hand adjusting a prefilled syringe with a dose-setting mechanism. The visual demonstrates how to set the dose by turning or sliding a part of the syringe, indicated by a large downward arrow and the text "Set your dose" next to the syringe.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 07

An instructional illustration showing two hands handling a syringe injection device. One hand holds the syringe barrel while the other hand is pulling or pushing the needle cap with arrows indicating removal or attachment direction. The image suggests proper technique for preparing the syringe for subcutaneous injection.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 08

Illustration showing a hand holding a small square applicator or swab, pressing it against the lower abdomen of a person, likely depicting the method to prepare or clean the injection site for subcutaneous injection.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 09

Illustration depicting the injection site areas recommended for subcutaneous administration of medication in the abdominal region. The areas are shaded rectangles on the left and right sides of the abdomen, avoiding the central area around the navel.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 10

Illustration of a syringe filled with a clear liquid, labeled as Enoxaparin Sodium injection. The diagram highlights the clear liquid inside the syringe, used for subcutaneous administration.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 11

An illustration showing a labeled injection syringe with a plunger on the right and needle on the left. The label points to the area near the syringe barrel where the expiration date can be found. The syringe is empty and presented in a side view.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 12

An instructional illustration showing a hand holding a prefilled syringe containing Enoxaparin Sodium injection, positioned within a molded tray. The syringe is being held around the barrel, showing proper hand placement for administration by subcutaneous injection.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 13

An instructional illustration showing components for administering Enoxaparin Sodium Injection subcutaneously. It includes an enoxaparin sodium injection syringe, a sharps disposal container, one cotton ball or gauze, one alcohol wipe, and one small adhesive bandage, all labeled accordingly.*

FDA Label Image

Bc9f03ca 569e 4194 Ba1d 38eeee7cb56f 14

Illustration showing the components and states of a prefilled injection syringe before and after use. The labeled parts include the plunger rod, needle with needle cover before use, and the protective sleeve after use. This diagram demonstrates proper handling of the syringe for subcutaneous injection.*

FDA Label Image

Instructions 1 (Enoxaparin 00)

An instructional illustration showing the correct and incorrect technique for handling a prefilled syringe of Enoxaparin Sodium injection. The left panel demonstrates holding the syringe properly with fingers away from the plunger, while the right panel shows a crossed-out example of improper finger placement on the plunger.*

FDA Label Image

Instructions 2 (Enoxaparin 01)

An instructional illustration showing two hands preparing a syringe for injection. One hand holds the syringe barrel with a thumb pressing the plunger, and arrows indicate the motion of the plunger being pushed and pulled. This image is likely part of an administration or usage guide for Enoxaparin Sodium injection.*

FDA Label Image

Instructions 3 (Enoxaparin 02)

An instructional line drawing showing how to use a safety syringe with activation prongs. The image highlights a hand holding the syringe and includes a caution not to touch the safety device activation prongs, indicating proper handling technique.*

FDA Label Image

Instructions 4 (Enoxaparin 03)

An instructional illustration depicting a hand holding a vial or syringe near an injection site on a person's arm, demonstrating the technique for subcutaneous administration. This image relates to the Enoxaparin Sodium injection, used for subcutaneous delivery.*

FDA Label Image

Instructions 5 (Enoxaparin 04)

An instructional illustration showing a hand pulling back a sleeve to expose the forearm, likely demonstrating preparation or administration of a subcutaneous injection.*

FDA Label Image

Instructions 6 (Enoxaparin 05)

An instructional illustration showing a hand holding a syringe-like device aimed to insert or remove something from a rectangular container with a hinged lid. The image appears to demonstrate proper handling or usage technique for a medical or pharmaceutical product, possibly related to injection or sample preparation.*

FDA Label Image

Chemical Structure (Enoxaparin 06)

Chemical structure diagram of enoxaparin sodium, depicting the molecular arrangement of its polysaccharide chains with associated functional groups, as relevant to the active ingredient in Enoxaparin Sodium injection by BluePoint Laboratories.*

FDA Label Image

Chemical Structure (Enoxaparin 07)

Chemical structure of enoxaparin sodium, depicting the molecular arrangement relevant to the active ingredient in the Enoxaparin Sodium injection by BluePoint Laboratories.*

FDA Label Image

Figure 1 (Enoxaparin 08)

A forest plot displaying relative risk comparisons between enoxaparin sodium and unfractionated heparin (UFH) across multiple patient subgroups, including sex, age, infarct location, diabetes history, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI status. The plot includes numerical values for UFH and enoxaparin percentages plus risk reduction, with a reference line at relative risk 1.0 indicating enoxaparin’s comparative effectiveness.*

FDA Label Image

Figure 2 (Enoxaparin 09)

A survival curve chart comparing the heart attack or death rates over 30 days between Enoxaparin and UFH treatments. The x-axis represents time in days, and the y-axis shows the hazard of death or heart attack. An inset graph depicts similar survival data over one year with corresponding statistical test results.*

FDA Label Image

Enoxaparin Sodium Injection 30mg/ 0.3ml Syringe Label (Image 01)

Packaging label for Enoxaparin Sodium Injection, 30 mg/0.3 mL prefilled syringe by BluePoint Laboratories. The label includes dosage form as subcutaneous injection, storage instructions, safety warnings, and RX only designation. It also shows syringe handling instructions with illustrations, NDC 68001-457-43, and contact information for user inquiries.*

FDA Label Image

Enoxaparin Sodium Injection 60mg/ 0.6ml (Image 02)

Packaging label for Enoxaparin Sodium Injection 60 mg/0.6 mL prefilled syringe by BluePoint Laboratories. The label includes directions for use of the syringe's safety device with illustrations showing how to peel the lid and safely lift the syringe. The label contains warnings about subcutaneous injection storage, child safety, and a contact number for side effect reporting. The NDC 68001-459-43 is visible along with lot and stock numbers.*

FDA Label Image

Enoxaparing Sodium Injection 40mg/0.4ml Syringe Label (Image 03)

Packaging label for Enoxaparin Sodium Injection 40 mg/0.4 mL, a subcutaneous injection by BluePoint Laboratories. The label includes storage instructions at 25°C (77°F), warnings to keep out of reach of children, and directions for use with a single-dose prefilled syringe with safety device. It shows manufacturer information (Amphastar Pharmaceuticals, Rancho Cucamonga, CA) and images illustrating syringe usage steps. NDC code 68001-458-43 is visible.*

FDA Label Image

Enoxaparin Sodium Injection 80mg/ 0.8ml Syringe Label (Image 04)

Enoxaparin Sodium Injection 80 mg/0.8 mL prefilled syringe label for subcutaneous injection. The label includes storage instructions (store at 25°C), a warning to keep out of reach of children, and a note that it is for prescription use only. Manufacturer is Amphastar Pharmaceuticals and BluePoint Laboratories. Illustrations show proper removal of the syringe peel lid and caution not to remove syringe by pulling on the plunger. The label displays NDC 68001-460-43 with barcode and lot/stock number areas.*

FDA Label Image

Enoxaparin Sodium Injection 100mg/ml Syringe Label (Image 05)

Packaging label for Enoxaparin Sodium Injection 100 mg/mL, a subcutaneous injection. The label includes storage instructions, warnings, manufacturer details (BluePoint Laboratories by Amphastar Pharmaceuticals), and directions with images on how to use the prefilled syringe safely. The NDC number 68001-461-43 and barcode are also visible.*

FDA Label Image

Enoxaparing Sodium Injection 120mg/ 0.8ml Syringe Label (Image 06)

Packaging label for Enoxaparin Sodium Injection 120 mg/0.8 mL, a subcutaneous injection by BluePoint Laboratories. The label includes storage instructions, warnings about keeping out of reach of children, and notes it is a single-dose prefilled syringe with a safety device. Illustrations show how to use and dispose of the syringe properly. The label features the NDC 68001-462-43 and contact information for medical inquiries and FDA side effect reporting.*

FDA Label Image

Enoxaparin Sodium Injection 150mg/ml Syringe Label (Image 07)

Enoxaparin Sodium Injection 150 mg/mL label for single-dose prefilled syringe with safety device. The label includes instructions for use, storage conditions at 25°C, warnings, NDC 68001-463-43, manufacturer Amphastar Pharmaceuticals distributed by BluePoint Laboratories, and a barcode. It specifies subcutaneous injection and contains safety and regulatory information.*

FDA Label Image

Enoxaparin Sodium 300mg/3ml Vial Label (Image 08)

Label for Enoxaparin Sodium Injection, USP 300 mg/3 mL (100 mg/mL) multiple dose vial. The label states the drug is for subcutaneous or intravenous injection and is manufactured for BluePoint Laboratories by Amphastar Pharmaceuticals, Inc. Storage instructions specify 20° to 25°C (68° to 77°F) with a 28-day usage limit after first use. NDC 68001-464-41 is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.